Editorial Board
- Medicinal Chemistry Section
- Biopharmaceuticals Section
- Natural Products Section
- Radiopharmaceutical Sciences Section
- Pharmacology Section
- Pharmaceutical Technology Section
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Interests: theranostic radioligands; targeted radionuclide therapies; targeted alpha therapies; combination therapies; molecular imaging; pharmaceutical radiochemistry; coordination and bioinorganic chemistry; radionuclide production and separation methods
Special Issues, Collections and Topics in MDPI journals
Interests: chemistry of heterocyclic compounds; microwave-assisted chemistry; sustainable methodologies; green chemistry applied to bioactive compounds: kinase inhibitors; Alzheimer's disease; down syndrome; cancer
Special Issues, Collections and Topics in MDPI journals
Interests: neuroscience; peptides; steroids
Special Issues, Collections and Topics in MDPI journals
Interests: immune suppression; embryonic stem cells; mesenchymal stem cells; immunogenicity; regenerative medicine; neural stem cells
Interests: organic synthesis; drug design and development; sulfur compounds; cyclophanes; flavonoids; acetylenes; allenes
Interests: gastroenterology; hepatology; drug-induced liver injury; gastrointestinal bleeding; liver cirrhosis; pancreatitis
2. Chefarzt der Klinik für Neurologie am EV, Krankenhaus, Mettmann, Germany
Interests: cerebrovascular diseases such ischemic or hemorrhagic stroke, SAH, different forms of hydrocephali, the blood-brain barrier and the so-called glymphatic system
Interests: physical chemistry; photonics; time resolved fluorescence spectroscopy; fluorescence microscopy; nanotechnology; cancer; nanomedicine; biosensors
Special Issues, Collections and Topics in MDPI journals
Interests: solid state chemistry; pair distribution function; synchrotron x-ray diffraction; solid nanoparticles; drug quality; polymorphs; salts; cocrystals; amorphous forms
Special Issues, Collections and Topics in MDPI journals
Interests: small molecule drug discovery for parasitic protozoa and helminths; 'neglected' tropical diseases; high-throughput and high content screening; proteolysis
Interests: topical drug delivery systems; dermal absorption; skin models; in vitro studies; nanomedicine; transdermal delivery; transmucosal delivery; cronocosmetic
Special Issues, Collections and Topics in MDPI journals
Interests: skin diseases; epithelial tumors (basaloma, actinic keratoses); antiproliferative; anti-infective; immunomodulatory
Special Issues, Collections and Topics in MDPI journals
Interests: ion channels; skin diseases; liver fibrosis
Interests: medicinal chemistry; drug discovery; small molecules; antitumor agents; kinase inhibitors; synthetic lethality
Special Issues, Collections and Topics in MDPI journals
Interests: marine alkaloids; heterocycles; drug discovery; synthesis; bioactive compounds; antitumor activity; antibiofilm activity; kinase inhibitors; small molecules
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; rational drug design; heterocyclic compounds; structure–activity relationships; adenosine receptor ligands; carbonic anhydrase inhibitors; protein kinase CK1 and CK2 inhibitors; ecto-5′-nucleotidase (CD73) inhibitors
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; anticancer drugs; nutraceuticals; multi-target agents; bioactive products; natural extracts; antioxidant activity; anti-inflammatory activity; cancer
Special Issues, Collections and Topics in MDPI journals
Interests: bioactive natural products; antibacterial activity; anti-inflammatory activity; anticancer activity
Interests: natural antioxidants; reactive oxygen species (ROS); mitochondrial biogenesis; antioxidant effects; anti-inflammatory, anti-cancer, anti-apoptotic, and anti-autophagy properties
Special Issues, Collections and Topics in MDPI journals
Interests: peptide-based drugs; peptide chemistry; G protein-coupled receptors; pharmacology; cardiovascular pharmacology; allosteric modulators; biased agonists
Special Issues, Collections and Topics in MDPI journals
Interests: natural product; isolation; structure identification; physicochemical properties; bioactivity; structure-activity relationship; mechanism
Special Issues, Collections and Topics in MDPI journals
2. National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD, USA
Interests: drug resistance mechanisms in human cancer; stem cells; drug discovery; regenerative medicine
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; fragment-based drug design; structure-based drug design; antiviral agents; anti-cancer agents; methyltransferase inhibitors; sirtuin inhibitors; histone deacetylase inhibitors; nucleosides; nucleotides
Special Issues, Collections and Topics in MDPI journals
Interests: psychiatry; neuropsychopharmacology; addiction; SUD; drugs; toxicology; new psychoactive substances
Special Issues, Collections and Topics in MDPI journals
Interests: notch pathway; signal transduction, cancer cell biology; tumor microenvironment; extracellular vesicles.
Interests: albumin; liposome; drug delivery; enhanced permeability retention effect; protein; functionalization of plasma proteins for pharmaceutical applications
Special Issues, Collections and Topics in MDPI journals
Interests: GPCR-targeting compounds; enzymes; QSAR; virtual screening; computational methods; drug design; pharmacophore modeling
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; organic synthesis; drug discovery; anticancer activity; antimicrobial activity; chiral drugs; natural products
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; rational drug design; heterocyclic compounds; structure–activity relationships; adenosine receptor ligands; carbonic anhydrase inhibitors; protein kinase CK1 and CK2 inhibitors; ecto-5′-nucleotidase (CD73) inhibitors
Special Issues, Collections and Topics in MDPI journals
2. Department of Chemistry and Pharmacy, Faculty of Science and Technology, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal
Interests: physical organic chemistry; organic reactivity; medicinal chemistry; bioactive heterocyclic compounds; antiparasitic compounds
Special Issues, Collections and Topics in MDPI journals

























